JP Morgan Chase’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.4M Sell
1,008,314
-77,205
-7% -$4.19M ﹤0.01% 1333
2025
Q4
$50.1M Sell
1,085,519
-479,517
-31% -$21.4M ﹤0.01% 1367
2025
Q3
$56.4M Buy
1,565,036
+366,266
+31% +$12.1M ﹤0.01% 1336
2025
Q2
$39M Sell
1,198,770
-701,409
-37% -$23M ﹤0.01% 1481
2025
Q1
$71.8M Buy
1,900,179
+164,516
+9% +$13.2M 0.01% 1101
2024
Q4
$142M Buy
1,735,663
+307,903
+22% +$30.6M 0.01% 790
2024
Q3
$163M Buy
1,427,760
+215,317
+18% +$19.4M 0.01% 764
2024
Q2
$91.6M Buy
1,212,443
+50,666
+4% +$3.45M 0.01% 946
2024
Q1
$79.4M Buy
1,161,777
+756,443
+187% +$52.4M 0.01% 1050
2023
Q4
$25.5M Sell
405,334
-232,387
-36% -$12.1M ﹤0.01% 1649
2023
Q3
$32.5M Buy
637,721
+281,312
+79% +$13.9M ﹤0.01% 1339
2023
Q2
$17.8M Buy
356,409
+63,513
+22% +$3.01M ﹤0.01% 1788
2023
Q1
$11M Buy
292,896
+39,964
+16% +$1.7M ﹤0.01% 2191
2022
Q4
$12.1M Buy
252,932
+72,805
+40% +$2.86M ﹤0.01% 2079
2022
Q3
$4.32M Buy
180,127
+135,955
+308% +$3.45M ﹤0.01% 2864
2022
Q2
$961K Buy
44,172
+17,380
+65% +$402K ﹤0.01% 4128
2022
Q1
$647K Buy
26,792
+6,390
+31% +$140K ﹤0.01% 4538
2021
Q4
$486K Sell
20,402
-5,655
-22% -$132K ﹤0.01% 4862
2021
Q3
$661K Buy
26,057
+4,176
+19% +$101K ﹤0.01% 4567
2021
Q2
$493K Sell
21,881
-43,064
-66% -$882K ﹤0.01% 4706
2021
Q1
$1.28M Buy
64,945
+27,454
+73% +$691K ﹤0.01% 4038
2020
Q4
$996K Buy
37,491
+30,703
+452% +$1.14M ﹤0.01% 3971
2020
Q3
$350K Buy
+6,788
New +$270K ﹤0.01% 4135

Other funds holding PCVX